Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (31-40 of 312) with videos related to

Pageof 32
Sort By:
Biomed Research International|August 20, 2014
Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancerJonathan D Grant, Joe Y Chang
International Journal of Radiation Oncology, Biology, Physics|May 13, 2006
The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volumeChristopher Nelson, George Starkschall, Joe Y Chang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learnedJoe Y Chang, Andrea Bezjak, Françoise Mornex, et al.
Translational Lung Cancer Research|September 27, 2019
Treatment modes for EGFR mutations in patients with brain metastases from non-small cell lung cancer: controversy, causes, and solutionsHongqing Zhuang, Siyu Shi, Joe Y Chang
Frontiers in Oncology|July 12, 2019
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?Eric D Brooks, Vivek Verma, Joe Y Chang
Pulmonary Medicine|August 18, 2012
Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancerDaniel R Gomez, Yuzuru Niibe, Joe Y Chang
Lancet (London, England)|July 20, 2024
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' replyJoe Y Chang, Vivek Verma, John V Heymach
Translational Lung Cancer Research|June 8, 2018
Proton therapy for early-stage non-small cell lung cancer (NSCLC)Daniel R Gomez, Heng Li, Joe Y Chang
Current Oncology Reports|June 11, 2005
Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancerJoe Y Chang, H Helen Liu, Ritsuko Komaki
European Journal of Cancer (Oxford, England : 1990)|March 2, 2024
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equalJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 32

Showing results (31-40 of 312) with videos related to

Sort By:
Pageof 32
Biomed Research International|August 20, 2014
Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancerJonathan D Grant, Joe Y Chang
International Journal of Radiation Oncology, Biology, Physics|May 13, 2006
The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volumeChristopher Nelson, George Starkschall, Joe Y Chang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learnedJoe Y Chang, Andrea Bezjak, Françoise Mornex, et al.
Translational Lung Cancer Research|September 27, 2019
Treatment modes for EGFR mutations in patients with brain metastases from non-small cell lung cancer: controversy, causes, and solutionsHongqing Zhuang, Siyu Shi, Joe Y Chang
Frontiers in Oncology|July 12, 2019
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?Eric D Brooks, Vivek Verma, Joe Y Chang
Pulmonary Medicine|August 18, 2012
Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancerDaniel R Gomez, Yuzuru Niibe, Joe Y Chang
Lancet (London, England)|July 20, 2024
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' replyJoe Y Chang, Vivek Verma, John V Heymach
Translational Lung Cancer Research|June 8, 2018
Proton therapy for early-stage non-small cell lung cancer (NSCLC)Daniel R Gomez, Heng Li, Joe Y Chang
Current Oncology Reports|June 11, 2005
Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancerJoe Y Chang, H Helen Liu, Ritsuko Komaki
European Journal of Cancer (Oxford, England : 1990)|March 2, 2024
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equalJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 32